83 related articles for article (PubMed ID: 28745988)
1. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Ludvigsson J; Tavira B; Casas R
N Engl J Med; 2017 Jul; 377(4):403-5. PubMed ID: 28745988
[No Abstract] [Full Text] [Related]
2. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Haller M; Atkinson M; Schatz D
N Engl J Med; 2017 Jul; 377(4):403. PubMed ID: 28748691
[No Abstract] [Full Text] [Related]
3. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Ludvigsson J; Wahlberg J; Casas R
N Engl J Med; 2017 Feb; 376(7):697-699. PubMed ID: 28199812
[No Abstract] [Full Text] [Related]
4. Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route.
Ludvigsson J
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111075
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
6. Comment on Rondas et al. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes 2015;64:573-586.
Yu WL; Sun Y
Diabetes; 2015 Mar; 64(3):e4. PubMed ID: 25713204
[No Abstract] [Full Text] [Related]
7. Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificity.
Bach JF; Chatenoud L
Chem Immunol; 1995; 60():32-47. PubMed ID: 7531979
[No Abstract] [Full Text] [Related]
8. [Vaccination against type 1 diabetes at the clinical trial stage].
Lernmark A
Lakartidningen; 1999 Mar; 96(11):1300-2. PubMed ID: 10194908
[TBL] [Abstract][Full Text] [Related]
9. Insulin as an autoantigen in NOD/human diabetes.
Zhang L; Nakayama M; Eisenbarth GS
Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus.
Doran TM; Morimoto J; Simanski S; Koesema EJ; Clark LF; Pels K; Stoops SL; Pugliese A; Skyler JS; Kodadek T
Cell Chem Biol; 2016 May; 23(5):618-628. PubMed ID: 27185639
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
Elding Larsson H; Lundgren M; Jonsdottir B; Cuthbertson D; Krischer J;
Pediatr Diabetes; 2018 May; 19(3):410-419. PubMed ID: 29171140
[TBL] [Abstract][Full Text] [Related]
12. Assignment of Ptprn2, the gene encoding receptor-type protein tyrosine phosphatase IA-2beta, a major autoantigen in insulin-dependent diabetes mellitus, to mouse chromosome region 12F.
van den Maagdenberg AM; Schepens JT; Schepens MT; Pepers B; Wieringa B; van Kessel AG; Hendriks WJ
Cytogenet Cell Genet; 1998; 82(3-4):153-5. PubMed ID: 9858807
[TBL] [Abstract][Full Text] [Related]
13. Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.
Nakayama M; Simmons KM; Michels AW
Curr Diab Rep; 2015 Dec; 15(12):113. PubMed ID: 26458384
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin: a unique autoantigen triggering autoimmune diabetes.
You S; Chatenoud L
J Clin Invest; 2006 Dec; 116(12):3108-10. PubMed ID: 17143326
[TBL] [Abstract][Full Text] [Related]
16. Autoantigens in type 1 diabetes mellitus.
Dotta F; Anastasi E; Tiberti C; Di Mario U
J Endocrinol Invest; 1994; 17(7):497-508. PubMed ID: 7829824
[No Abstract] [Full Text] [Related]
17. Insulin--a primary autoantigen in type 1 diabetes?
Wong FS
Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
Muir A; Schatz DA; Maclaren NK
Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
[TBL] [Abstract][Full Text] [Related]
19. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
20. Influence of maternal hyperglycaemia on cord blood mononuclear cells in response to diabetes-associated autoantigens.
Stechova K; Spalova I; Durilova M; Bartaskova D; Cerny M; Cerna M; Pithova P; Chudoba D; Stavikova V; Ulmannova T; Faresjö M
Scand J Immunol; 2009 Aug; 70(2):149-58. PubMed ID: 19630921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
